Medindia

X

Symic Bio to Present at Upcoming Conferences

Monday, February 6, 2017 General News J E 4
Advertisement
­- Chief Executive Officer Ken Horne to present at the BIO CEO & Investor Conference 2017 and the Cowen Health Care Conference ­-

SAN FRANCISCO, Feb. 6, 2017 /PRNewswire/ -- Symic Bio, a clinical-stage biotech company that is developing a new category of therapeutics focused on matrix biology, today announced that Ken Horne, Chief Executive Officer, will present at the following upcoming events:

BIO CEO & Investor Conference

Date: Monday, Feb. 13, 2017

Time: 9:30 a.m. EST

Location: Waldorf Astoria, New York

Cowen and Company Health Care Conference

Date: Monday, March 6, 2017

Time: 3:30 p.m. EST

Location: Boston Marriott Copley Place

About Symic Bio

Symic Bio is a clinical-stage biotech company that is developing a new category of therapeutics that are matrix regulators. Matrix regulators target the non-cellular component of tissue and enable new ways to affect disease and healing processes. Matrix regulators have potential applications in a wide variety of indications. Symic Bio currently has two clinical candidates, SB-030 for the treatment of critical limb ischemia and SB-061 directed at disease modification in the treatment of osteoarthritis. In addition, Symic Bio is investigating applications in the areas of fibrosis, oncology and diseases of the central nervous system.

For additional information please visit the company's website at www.symic.bio, LinkedIn page at www.linkedin.com/company/symic-bio or follow on Twitter at www.twitter.com/symicbio.

Investor Contacts

Gitanjali Jain OgawaThe Trout Group(646) 378-2949gogawa@troutgroup.com

Media Contacts

David Schull or Rich AllanRusso Partners, LLC(212) 845-4271(646) 942-5588david.schull@russopartnersllc.com rich.allan@russopartnersllc.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/symic-bio-to-present-at-upcoming-conferences-300402276.html

SOURCE Symic Bio

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Gateway Health Compliance Director Osato Chitou Re...
S
Educator of the Year Award - Nominations Now Open